Unknown NA INTERVENTIONAL 4-arm NCT05081804

The Effect of Enhanced Recovery After Surgery (ERAS) for Cesarean Section on Neonatal Blood Glucose

The Effect of Enhanced Recovery After Surgery (ERAS) for Cesarean Section on Neonatal Blood Glucose - A Randomized Equivalency Trial

Sponsor: Nova Biomedical

Conditions Cesarean Section Enhanced Recovery After Surgery

Interventions Carbohydrate Preoperative Drink

Updated 5 times since 2021 Last updated: May 15, 2023 Started: Oct 20, 2021 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05081804, this NA trial focuses on Cesarean Section and Enhanced Recovery After Surgery and remains ongoing. Sponsored by Nova Biomedical, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Jun 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Jun 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jun 2023 — Jul 2024 [monthly]

Recruiting NA
Nov 2021 — Jun 2023 [monthly]

Recruiting NA

First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nova Biomedical
University of Arizona

Data source: University of Arizona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tucson, United States